PubPeer
The online Journal club
login
create account
Home
Publications
The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation
Cancer Research (2007) -
Comments
pubmed: 17909059 doi: 10.1158/0008-5472.can-07-0598 issn: 0008-5472 issn: 1538-7445
Roberto R. Rosato, Jorge A. Almenara, Stefanie Coe, Steven Grant
Go to article
Go to preprint
American Association for Cancer Research (AACR)
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})